WARN : Please note that some of the values may not be in base currency

Fundamental Analysis of Aptose Biosciences Inc - Growth / Value Index


APTO - Valuation Highlights

Valuation Analysis

   Price to Book Ratio is 0.380 indicating that it is undervalued.
   Tsr Value Index - Very Poor Score of 5.00
   Book Value in last 3 years is trending down
   Book value is negative
Valuation Key Ratios
Ratio TTM Latest FY Yoy Change MRQ
Price to Earning -0.170 -0.162 3.42 %
Price to Book 0.899 -2.75 -1579.70 % 113.23
Price to Sales 11.31 0 0 %
Enterprise Value to EBITDA Multiple -0.217 0.0182 -97.47 %


APTO - Profitability Highlights

Profitability Analysis

   Strong Return On Capital Employed of 1697.76
   Company Earning excess return
   Tsr Profitability Index - Very Poor Score of 5.00
   Piotroski F Score - Very Poor Value of 2.0
   Negative Net profit for last two years
   Company Net profit is Negative for last 5 Quarters
   In the last three years, the company has given poor Net Margin
   In the last three years, the company has given poor Returns on Equity
   In the last three years, the company has given poor Returns on Assets
   Negative Net Margin MRQ
Profitability Key Ratios
Ratio TTM Latest FY Yoy Change MRQ
Return On Equity -529.60 0 0 % -7012.33
Return On Asset -210.95 -379.18 -362.63 % -75.08
Net Profit Margin -6663.57 0 0 % 0
Operating Profit Margin -6705.16 0 0 % 0
EBITDA Margin -6674.06 0 0 % 0


Highlights
Market Cap19177.48 K
Enterprise Value10319.48 K
Price/Book TTM0.899
Outstanding Share16252.10 K
Float/ Outstanding Share77.10%
Dividend Yield2.06 %
Share Holding
Guru Numbers
Price/Graham No0
Peter Lynch Ratio0
Piotroski F Score2.00
Altman Z Score-67.39
Sloan Ratio-0.406
Peter Lynch Fair Value0


APTO - Growth Highlights

Growth Analysis

   Annual sales of the company is increased for three years in a row
   Quarterly sales in last 5 years is trending up
   Tsr Growth Index - Very Poor Score of 10.09
   Annual sales in last 3 years is trending down
   Company's Total Assets is Decreasing for last 3 years
   Operating Cash Flow decreasing for last 3 year
Growth Key Fields
Field TTM YoY Growth QoQ Growth
Revenue 712206 % 100.00 %
Gross Profit -446647.00 6.42 % 4.00 %
EBITDA -47533.02 K 18.16 % 22.20 %
Net Profit -47458.36 K 17.76 % 21.88 %
EPS -6.95 3.54 % NA


APTO - Stability Highlights

Stability Analysis

   Debt to equity ratio has decreased and is lowest in last five years
   Tsr Stability Index - Very Poor Score of 5.00
   Altman Z Score of -67.36 suggest high risk
   Company is unable to generate enough free cash to support the business.
   Interest Coverage of 0
Stability Key Ratios
Ratio Latest FY Yoy Change MRQ
Debt to Equity Ratio -0.136 -1802.92 % 2.91
Cash Ratio 0.606 -84.15 %
Quick Ratio 0 0 % 0.974
Shareholders Equity -22.33 -130.20 %
Debt to EBITDA -0.0081 -10.78 %


Historical Valuation Ratios of Aptose Biosciences Inc

Historical Valuation Ratios
Loading ...

Historical Profitability Ratios of Aptose Biosciences Inc

Historical Profitability Ratios
Loading ...

Historical Efficiency Ratios of Aptose Biosciences Inc

Historical Efficiency Ratios
Loading ...

Historical Solvency Ratios of Aptose Biosciences Inc

Historical Solvency Ratios
Loading ...


Note : All Data Generated at the End of Trading Hours (EOD Data)